Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Phase I-part: To determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of ZK 219477 in combination with cisplatin To investigate the safety and tolerability of ZK 219477 in combination with cisplatin Phase II-part: To evaluate the anti-tumor activity of ZK 219477 in combination with cisplatin in patients with chemotherapy-naive, extensive-disease stage small cell lung cancer
Inclusion criteria
- Extensive disease (ED) stage small-cell lung cancer (SCLC)